SNDX
Syndax Pharmaceuticals Inc
$22.89
-0.72 (-3.05%)
At close · Jul 13
Market Cap
$2.03B
Shares
88,610,027
Total shares sold short and not yet covered, reported to FINRA by broker-dealers and published twice a month (bi-monthly). Days to cover divides the short position by average daily volume; a high value (above 5) can signal short-squeeze potential.
Short Squeeze Score
86/100
Short interest 24.6% of shares — P99
Days to cover 8.6 — P93
Price vs VWAP +11.2% — P87
Short-volume trend +3.5% — P65
Short interest change +9.9% — P66
Worst FTD 0.11% of shares — P82
Peer-relative percentile rank across all stocks reporting short interest at the latest settlement date (2026-06-30). Weighted mean of the available factors (short interest 30%, days to cover 20%, price vs VWAP 15%, short-volume trend 15%, short-interest change 10%, fails-to-deliver 10%) plus catalyst boosts (price spike, volume surge, earnings within days), capped at +20 and clamped to 100.
Short Interest History
| Settlement Date | Current Position | Previous Position | Change | Days to Cover |
|---|---|---|---|---|
| 2026-06-30 | 21,812,785 | 19,855,525 | +1,957,260 | 8.56 |
| 2026-06-15 | 19,855,525 | 16,637,071 | +3,218,454 | 9.10 |
| 2026-05-29 | 16,637,071 | 21,712,664 | -5,075,593 | 16.02 |
| 2026-05-15 | 21,712,664 | 19,911,327 | +1,801,337 | 10.54 |
| 2026-04-30 | 19,911,327 | 20,968,088 | -1,056,761 | 12.66 |
| 2026-04-15 | 20,968,088 | 20,695,810 | +272,278 | 15.24 |
| 2026-03-31 | 20,695,810 | 20,485,613 | +210,197 | 13.63 |
| 2026-03-13 | 20,485,613 | 21,798,656 | -1,313,043 | 13.48 |
| 2026-02-27 | 21,798,656 | 22,117,950 | -319,294 | 19.86 |
| 2026-02-13 | 22,117,950 | 21,147,220 | +970,730 | 17.85 |
| 2026-01-30 | 21,147,220 | 22,344,466 | -1,197,246 | 17.22 |
| 2026-01-15 | 22,344,466 | 22,569,116 | -224,650 | 16.06 |
| 2025-12-31 | 22,569,116 | 22,826,193 | -257,077 | 18.21 |
| 2025-12-15 | 22,826,193 | 25,221,608 | -2,395,415 | 12.48 |
| 2025-11-28 | 25,221,608 | 25,622,767 | -401,159 | 10.65 |
| 2025-11-14 | 25,622,767 | 25,344,944 | +277,823 | 7.59 |
| 2025-10-31 | 25,344,944 | 22,023,042 | +3,321,902 | 5.92 |
| 2025-10-15 | 22,023,042 | 22,807,077 | -784,035 | 10.96 |
| 2025-09-30 | 22,807,077 | 23,141,658 | -334,581 | 10.98 |
| 2025-09-15 | 23,141,658 | 20,917,832 | +2,223,826 | 12.77 |
| 2025-08-29 | 20,917,832 | 20,605,895 | +311,937 | 9.76 |
| 2025-08-15 | 20,605,895 | 23,902,315 | -3,296,420 | 5.62 |
| 2025-07-31 | 23,902,315 | 23,691,424 | +210,891 | 13.62 |
| 2025-07-15 | 23,691,424 | 23,867,422 | -175,998 | 13.26 |
Showing 1–24 of 24 settlements
Key facts
CIK
1395937
CUSIP
87164F105
13F (30d)
11 filings
10 filers
Visit website
Investor relations